Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 145.25
-3.75 (-2.52%)
Aug 12, 2026, 10:24 AM GMT
Diaceutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Diaceutics stock has a consensus rating of "Strong Buy" and an average price target of 213p. The average 1-year stock price forecast is 46.64% higher than the current stock price, while the lowest is 185p (+27.37%) and the highest is 235p (+61.79%).
Price Target: 213p (+46.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Diaceutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Jan '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Canaccord Genuity No rating | Canaccord Genuity | Buy Reiterates 215p | Buy | Reiterates | 215p | +48.02% | Jul 29, 2026 |
Financial Forecast
Revenue This Year
46.72M
from 38.44M
Increased by 21.55%
Revenue Next Year
56.34M
from 46.72M
Increased by 20.60%
EPS This Year
0.01
from 0.01
Increased by 9.21%
EPS Next Year
0.04
from 0.01
Increased by 388.67%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.